[HTML][HTML] Microbiota in health and diseases
The role of microbiota in health and diseases is being highlighted by numerous studies
since its discovery. Depending on the localized regions, microbiota can be classified into …
since its discovery. Depending on the localized regions, microbiota can be classified into …
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …
FLJ Visseren, F Mach, YM Smulders… - European journal of …, 2022 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
Chronic kidney disease
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …
mortality that occurs commonly in the general adult population, especially in people with …
[HTML][HTML] Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
Background The risk of severe COVID-19 if an individual becomes infected is known to be
higher in older individuals and those with underlying health conditions. Understanding the …
higher in older individuals and those with underlying health conditions. Understanding the …
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
LB Hilbrands, R Duivenvoorden, P Vart… - Nephrology Dialysis …, 2020 - academic.oup.com
Background. Patients on kidney replacement therapy comprise a vulnerable population and
may be at increased risk of death from coronavirus disease 2019 (COVID-19). Currently …
may be at increased risk of death from coronavirus disease 2019 (COVID-19). Currently …
Solutions to the drawbacks of photothermal and photodynamic cancer therapy
X Deng, Z Shao, Y Zhao - Advanced Science, 2021 - Wiley Online Library
Phototherapy such as photothermal therapy and photodynamic therapy in cancer treatment
has been developed quickly over the past few years for its noninvasive nature and high …
has been developed quickly over the past few years for its noninvasive nature and high …
[HTML][HTML] Small-molecule fluorescence-based probes for interrogating major organ diseases
HH Han, H Tian, Y Zang, AC Sedgwick, J Li… - Chemical Society …, 2021 - pubs.rsc.org
Chemical tools that allow the real-time monitoring of organ function and the visualisation of
organ-related processes at the cellular level are of great importance in biological research …
organ-related processes at the cellular level are of great importance in biological research …
[HTML][HTML] The current and future landscape of dialysis
The development of dialysis by early pioneers such as Willem Kolff and Belding Scribner set
in motion several dramatic changes in the epidemiology, economics and ethical frameworks …
in motion several dramatic changes in the epidemiology, economics and ethical frameworks …
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …
N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[HTML][HTML] Dapagliflozin in patients with chronic kidney disease
HJL Heerspink, BV Stefánsson… - … England Journal of …, 2020 - Mass Medical Soc
Background Patients with chronic kidney disease have a high risk of adverse kidney and
cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease …
cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease …